Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/13 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 62
- 較 2021 年第 1 季 0
- 總值
- $2.10 億
- 較 2021 年第 1 季 +$591.5 萬 (+2.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BBIOBridgeBio Pharma, Inc. | COM | 550,000 | $3,353 萬 | 16.0% | −27,500−4.8% | 減碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 246,201 | $1,413 萬 | 6.7% | +51,201+26.3% | 加碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 838,311 | $1,089 萬 | 5.2% | +295,301+54.4% | 加碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 900,000 | $909.0 萬 | 4.3% | +900,000 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 425,000 | $886.1 萬 | 4.2% | +60,000+16.4% | 加碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 85,000 | $792.9 萬 | 3.8% | +35,000+70.0% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 142,418 | $757.7 萬 | 3.6% | +64,918+83.8% | 加碼 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 700,000 | $750.4 萬 | 3.6% | 00.0% | 不變 | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 55,000 | $690.2 萬 | 3.3% | +10,000+22.2% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 140,100 | $628.8 萬 | 3.0% | +90,100+180.2% | 加碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $599.3 萬 | 2.9% | – | – | – |
| RCKTRocket Pharmaceuticals, Inc. | COM | 120,000 | $531.5 萬 | 2.5% | +35,000+41.2% | 加碼 | 歷史 |
| CRISCuris Inc | COM NEW | 650,000 | $524.6 萬 | 2.5% | −350,000−35.0% | 減碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 200,000 | $512.4 萬 | 2.4% | −70,000−25.9% | 減碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 275,000 | $482.9 萬 | 2.3% | +52,733+23.7% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 250,000 | $354.5 萬 | 1.7% | +22,500+9.9% | 加碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 300,000 | $306.0 萬 | 1.5% | +75,000+33.3% | 加碼 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 300,000 | $289.5 萬 | 1.4% | +300,000 | 新進 | – |
| KDNYChinook Therapeutics, Inc. | COM | 200,000 | $282.4 萬 | 1.3% | +25,000+14.3% | 加碼 | 歷史 |
| LUNGPulmonx Corp | COM | 60,000 | $264.7 萬 | 1.3% | +15,000+33.3% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 20,000 | $263.1 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 100,000 | $260.2 萬 | 1.2% | +75,400+306.5% | 加碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 25,000 | $234.1 萬 | 1.1% | −10,000−28.6% | 減碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 200,000 | $226.6 萬 | 1.1% | −100,000−33.3% | 減碼 | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 380,000 | $225.0 萬 | 1.1% | 00.0% | 不變 | – |
| MGNXMacrogenics Inc | COM | 80,000 | $214.9 萬 | 1.0% | +55,000+220.0% | 加碼 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 650,000 | $206.1 萬 | 1.0% | −250,000−27.8% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 25,000 | $206.0 萬 | 1.0% | −2,000−7.4% | 減碼 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 70,000 | $200.0 萬 | 1.0% | −20,000−22.2% | 減碼 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 25,000 | $189.0 萬 | 0.9% | +25,000 | 新進 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 20,000 | $174.7 萬 | 0.8% | +10,000+100.0% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 25,000 | $168.7 萬 | 0.8% | +15,000+150.0% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 50,000 | $167.2 萬 | 0.8% | −80,000−61.5% | 減碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 10,000 | $161.9 萬 | 0.8% | +10,000 | 新進 | 歷史 |
| Gossamer Bio, Inc.38341PAA0 | NOTE 5.000% 6/0 | – | $160.5 萬 | 0.8% | – | 新進 | – |
| SNCEScience 37 Holdings, Inc. | COM | 150,000 | $150.0 萬 | 0.7% | −250,000−62.5% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 66,957 | $148.7 萬 | 0.7% | +66,957 | 新進 | 歷史 |
| BFLYButterfly Network, Inc. | COM CL A | 100,000 | $144.8 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 20,000 | $138.7 萬 | 0.7% | +7,500+60.0% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 70,000 | $138.5 萬 | 0.7% | +30,000+75.0% | 加碼 | 歷史 |
| AFIBAcutus Medical, Inc. | COM | 80,000 | $135.8 萬 | 0.6% | +20,000+33.3% | 加碼 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 50,000 | $119.8 萬 | 0.6% | −50,000−50.0% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 45,000 | $115.9 萬 | 0.6% | +45,000 | 新進 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 85,000 | $115.4 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 100,000 | $113.8 萬 | 0.5% | 00.0% | 不變 | – |
| PCVXVaxcyte, Inc. | COM | 50,000 | $112.6 萬 | 0.5% | +20,000+66.7% | 加碼 | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 72,466 | $104.3 萬 | 0.5% | 00.0% | 不變 | – |
| ZYMEZymeworks Inc. | COM | 30,000 | $104.1 萬 | 0.5% | −50,000−62.5% | 減碼 | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 15,000 | $97.2 萬 | 0.5% | +15,000 | 新進 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 300,000 | $93.3 萬 | 0.4% | 00.0% | 不變 | – |
| QSIQuantum-Si Inc | COM CL A | 75,000 | $92.0 萬 | 0.4% | +75,000 | 新進 | 歷史 |
| Chardan Healthcr Acqstn 2 Co15957T206 | UNIT 99/99/9999 | 75,000 | $81.9 萬 | 0.4% | 00.0% | 不變 | – |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 80,000 | $78.3 萬 | 0.4% | +55,000+220.0% | 加碼 | – |
| GBTGlobal Blood Therapeutics, Inc. | COM | 20,000 | $70.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 50,000 | $69.4 萬 | 0.3% | +30,000+150.0% | 加碼 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 190,000 | $65.4 萬 | 0.3% | −10,000−5.0% | 減碼 | – |
| ITOSiTeos Therapeutics, Inc. | COM | 25,000 | $64.1 萬 | 0.3% | +25,000 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 10,000 | $63.2 萬 | 0.3% | +10,000 | 新進 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 75,000 | $47.5 萬 | 0.2% | +25,000+50.0% | 加碼 | 歷史 |
| Beauty Health Co88331L116 | EQUITY WRT | 45,000 | $28.8 萬 | 0.1% | +45,000 | 新進 | – |
| CVRXCVRx, Inc. | COM | 7,500 | $21.0 萬 | 0.1% | +7,500 | 新進 | 歷史 |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $3.40 萬 | <0.1% | +33,333 | 新進 | – |
選擇權（7 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $2,708 萬 | – |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | $2,081 萬 | – |
| Curevac N VN2451R105 | COM | $1,102 萬 | – |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | – | $423.8 萬 |
| IONSIonis Pharmaceuticals Inc | COM | – | $299.2 萬 |
| MRNAModerna, Inc. | Stock | – | $293.7 萬 |
| IMVTImmunovant, Inc. | COM | – | $31.7 萬 |
2021 年第 1 季之後清倉（14 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 689,000 | $949.4 萬 | 4.7% | – |
| TVTXTravere Therapeutics, Inc. | COM | 220,000 | $549.3 萬 | 2.7% | 歷史 |
| Medicus Sciences AcquisitionG5960S116 | UNIT 99/99/9999 | 300,000 | $295.5 萬 | 1.4% | – |
| STROSutro Biopharma, Inc. | COM | 80,000 | $182.1 萬 | 0.9% | 歷史 |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | 150,000 | $178.8 萬 | 0.9% | – |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 218,000 | $88.1 萬 | 0.4% | – |
| CCCCC4 Therapeutics, Inc. | COM STK | 20,000 | $74.0 萬 | 0.4% | 歷史 |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 200,000 | $67.0 萬 | 0.3% | – |
| XFORX4 Pharmaceuticals, Inc | COM | 75,000 | $64.6 萬 | 0.3% | 歷史 |
| BYSIBeyondSpring Inc. | SHS | 50,000 | $55.4 萬 | 0.3% | 歷史 |
| EPZMEpizyme, Inc. | COM | 50,000 | $43.6 萬 | 0.2% | 歷史 |
| WINTWindtree Therapeutics Inc | COM | 42,847 | $10.5 萬 | 0.1% | 歷史 |
| Vesper Healthcare Acqstn Cor92538T112 | *W EXP 09/30/202 | 45,000 | $9.40 萬 | <0.1% | – |
| ZYNEZynerba Pharmaceuticals, Inc. | COM | 13,285 | $6.20 萬 | <0.1% | 歷史 |